Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01403064 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2 study, sponsored by CSL Behring.
- Terminated
- Registry status
- Phase 2
- Development phase
- 76
- Enrollment target
NCT01403064: Clinical Trial Phase 2 study, sponsored by CSL Behring.
NCT01403064 is a Phase 2 study that was terminated before completion, run by CSL Behring. The registered enrollment target is 76 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01403064, a Phase 2 study, was terminated before completion, sponsored by CSL Behring.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of ALD518 in modifying the course of oral mucositis in subjects with head and neck cancer receiving concomitant chemotherapy and radiotherapy
Interventions
- DRUG 0.9% saline
- BIOLOGICAL ALD518
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-03 |
| Phase | Phase 2 |
Why NCT01403064 stopped before completion
NCT01403064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 2 interventions - of which 0.9% saline is the first listed.
NCT01403064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01403064 about?
NCT01403064 is a clinical study titled "Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects". The purpose of this study is to evaluate the safety and efficacy of ALD518 in modifying the course of oral mucositis in subjects with head and neck cancer receiving concomitant chemotherapy and radiotherapy
What is the current status of trial NCT01403064?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 76 participants. The study started on 2011-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01403064?
The interventions under investigation include: 0.9% saline (DRUG), ALD518 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01403064?
This trial is sponsored by CSL Behring, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01403064's enrollment target sits among peer trials
76 893rd of 2000 higher than 1,101 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia